Clinical Trial Update: A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes the completion of a Phase I/II study evaluating UC1010 for Premenstrual Dysphoric Disorder (PMDD) conducted by Umecrine Mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Dysphoric Disorder

Drugs mentioned

• UC1010

Snippet

Sponsor: Umecrine Mood AB | Conditions: Premenstrual Dysphoric Disorder | Phase 1, Phase 2 | Status: COMPLETED